An analysis of the economic impact of drugcoated balloon use for the treatment of peripheral artery disease

An analysis of the economic impact of drugcoated balloon use for the treatment of peripheral artery disease

Background: Drug-coated balloons (DCBs) are an alternative for patients with peripheral arterial disease. Costs and re-intervention rates are potentially reduced compared to other technologies. We assessed the economic impact of these endovascular therapies. Methods An Italian National Healthcare Se...

Full description

Bibliographic Details
Main Authors:	Antonio Micari, Giuseppe Vadalà, Mara Corbo, Gianluigi D’Alessandro, Fausto Castriota, Alberto Cremonesi
Format:	Article
Language:	English
Published:	Barcaray International 2015-01-01
Series:	International Cardiovascular Forum Journal
Subjects:	drug-coated balloons peripheral artery disease health economics
Online Access:	http://icfjournal.org/index.php/icfj/article/view/115/pdf_2

Similar Items

Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date
by: Barkat M, et al.
Published: (2016-05-01)

New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
by: Naghi J, et al.
Published: (2016-06-01)

Avoiding revascularization strategy versus revascularization with drug-coated balloon for the treatment of superficial femoral artery occlusive disease
by: Hongcheng Ren, et al.
Published: (2021-05-01)

Prognostic Factors in Patients Treated with Drug-Coated Balloon Angioplasty for Symptomatic Peripheral Artery Disease
by: Fragiska Sigala, et al.
Published: (2018-12-01)

Real-world experience with a Paclitaxel-Coated Balloon for the treatment of atherosclerotic infrainguinal arteries: 12-month interim results of the BIOLUX P-III registry first year of enrolment
by: Marianne Brodmann, et al.

IN.PACTTM AdmiralTM drug-coated balloons in peripheral artery disease: current perspectives
by: Torii S, et al.
Published: (2019-02-01)

Progress on developing an effective below-the-knee drug-coated balloon
by: Rym El Khoury, et al.
Published: (2021-09-01)

Successful pulmonary artery balloon angioplasty in a rare case of arterial tortuosity syndrome
by: Maryam Aliramezany, et al.
Published: (2020-01-01)

Comparison of Effectiveness of Drug-Coated Balloon Angioplasty versus Plain Balloon Angioplasty in Chronic Lower Extremity Ischemia Patients
by: Nazari I, et al.
Published: (2020-09-01)

Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons
by: Emily Goel, et al.
Published: (2020-03-01)

Critical appraisal of paclitaxel balloon angioplasty for femoral–popliteal arterial disease
by: Herten M, et al.
Published: (2016-08-01)

One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial
by: Zhichao Lai, et al.
Published: (2020-02-01)

An update on vessel preparation in lower limb arterial intervention
by: William Ormiston, et al.
Published: (2020-11-01)

Resveratrol-Coated Balloon Catheters in Porcine Coronary and Peripheral Arteries
by: Stefanie Kamann, et al.
Published: (2019-05-01)

Atherectomy in Peripheral Artery Disease: Current and Future
by: Yohan Kwon, et al.
Published: (2021-05-01)

Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview
by: C. D. Ramakrishna, et al.
Published: (2017-06-01)

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial
by: Ulf Teichgräber, et al.
Published: (2021-09-01)

One-year outcomes of drug-coated balloon treatment for long femoropopliteal lesions: a multicentre cohort and real-world study
by: Xiaoxi Yu, et al.
Published: (2021-07-01)

Drug-eluting balloon: is it useful?
by: Sidhi Laksono, et al.
Published: (2020-11-01)

Aneurysmal Dilatation of the Superficial Femoral Artery After Endovascular Intervention
by: Sriya A. Avadhani, MD, et al.
Published: (2021-03-01)

Comparison of infrarenal aortic balloon occlusion with internal iliac artery balloon occlusion for patients with placenta accreta
by: Youwen Mei, et al.
Published: (2019-05-01)

Five-Year Outcomes of Post-Drug-Coated Balloon Angioplasty Dissection in Complex Femoropopliteal Artery Disease
by: Ren H, et al.
Published: (2021-08-01)

Drug-Coated Balloon-Only Percutaneous Coronary Intervention for the Treatment of De Novo Coronary Artery Disease: A Systematic Review
by: Hasan Mohiaddin, et al.
Published: (2018-10-01)

Sex Disparities in Long-Term Mortality after Paclitaxel Exposure in Patients with Peripheral Artery Disease: A Nationwide Claims-Based Cohort Study
by: Christian-Alexander Behrendt, et al.
Published: (2021-07-01)

Differential efficacy between stenting and plain balloon angioplasty for femoropopliteal disease with or without total occlusion
by: In-Ho Chae, et al.
Published: (2020-09-01)

Safety of balloon angioplasty for symptomatic intracranial artery stenosis
by: Yu-jie SUN, et al.
Published: (2019-10-01)

Effect of drug-coated balloons in treatment of stenosis of the femoral artery and vein bypass graft not responding to plain old balloon angioplasty: a case report
by: Sohei Matsuura, et al.
Published: (2019-12-01)

Short and long terms clinical outcomes of Paclitaxel drug-eluting balloons applied for de-novo coronary artery lesions in the context of acute coronary syndrome: A real world experience
by: Ahmed Ayuna, et al.
Published: (2021-05-01)

Drug-Eluting Balloon Angioplasty for Complex Femoropopliteal Lesions in Patients with End-Stage Renal Disease
by: Burak Teymen, et al.
Published: (2019-01-01)

Percutaneous Mechanical Atherectomy Plus Thrombectomy Using the Rotarex®S Device Followed by a Drug-Coated Balloon for the Treatment of Femoropopliteal Artery In-stent Restenosis: A Prospective Single-Center, Single-Arm Efficacy Trial (PERMIT-ISR Trial)
by: Ming-Yuan Liu, et al.
Published: (2021-09-01)

The treatment dilemma in adult patients with peripheral pulmonary artery stenosis of diverse etiologies
by: Zahra Hosseini, et al.
Published: (2021-07-01)

Intra-arterial Balloon Occlusion to Reduce Operative Bleeding for Placenta Previa Accreta Spectrum
by: Yoshihiko Murayama, et al.
Published: (2021-09-01)

Paclitaxel and mortality in patients with claudication and de novo femoropopliteal lesions: a historical cohort study
by: Gérald Gahide, et al.
Published: (2021-08-01)

In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons
by: Emily Turner, et al.
Published: (2018-07-01)

Infrequent origin of a peripheral embolism: Arterial thoracic outlet syndrome in a young woman
by: Berhan Keskin, et al.
Published: (2020-04-01)

Development and in Vitro Characterization of Photochemically Crosslinked Polyvinylpyrrolidone Coatings for Drug-Coated Balloons
by: Svea Petersen, et al.
Published: (2013-12-01)

Balloon angioplasty of severe aortic coarctation in a newborn, using axillary artery access: The first experience in Turkey
by: Kemal Nişli, et al.
Published: (2016-10-01)

Infrared Thermography as a Diagnostic Tool for the Assessment of Patients with Symptomatic Peripheral Arterial Disease Undergoing Infrafemoral Endovascular Revascularisations
by: Gladiol Zenunaj, et al.
Published: (2021-09-01)

The Paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: An angiographic follow up study
by: Upendra Kaul, et al.
Published: (2013-09-01)

A novel technique for treating visceral artery pseudoaneurysm: Selective arterial embolization with cut-inflateddeflated balloon
by: Yusuf Can, et al.
Published: (2020-07-01)